FORMIGRAM-GZ Tablet

What is FORMIGRAM‑GZ Tablet?

FORMIGRAM‑GZ Tablet SR contains Gliclazide 80 mg + Metformin 500 mg (SR) per tablet. Gliclazide is a sulfonylurea that increases pancreatic insulin release, and metformin is a biguanide that reduces liver glucose production and improves insulin sensitivity.​

Key Benefits

• Provides complementary dual action to lower fasting and post‑meal blood glucose and HbA1c more effectively than monotherapy.​

• Helps delay or reduce the risk of long‑term diabetes complications when used consistently with diet, exercise and regular monitoring.​

Uses & Indications

FORMIGRAM‑GZ Tablet SR is indicated for:​

• Adults with type 2 diabetes mellitus inadequately controlled with diet, exercise and/or metformin alone.​

• Patients who benefit from a fixed‑dose combination of gliclazide plus metformin to improve adherence and simplify their regimen.​

It is not used in type 1 diabetes or for managing diabetic ketoacidosis.​

Dosage & Directions

The exact dose schedule is determined by the treating physician.​

• Usual adult regimen: one tablet once or twice daily with meals, commonly with breakfast and/or dinner.​

• Tablets should be swallowed whole with water; do not crush or chew SR tablets.​

Blood glucose, kidney function and HbA1c should be monitored, and doses adjusted based on response, age and comorbidities.​

Price & Packaging

On Ingram’s product archive, FORMIGRAM‑GZ Tablet is listed at ₹130.00 MRP with an offer price of ₹110.50 for a strip (10 tablets). Other pharmacy listings show similar pricing bands, with retailer discounts affecting final consumer price.​

Strips are supplied in printed cartons showing strength, composition, batch number, manufacturing and expiry details, and Ingram Biosciences branding.​

Side Effects & Safety

Common side effects reported with gliclazide‑metformin combinations and specifically Formigram‑GZ include:​

• Hypoglycaemia: sweating, tremor, hunger, palpitations, confusion or headache.​

• Gastrointestinal symptoms: nausea, vomiting, diarrhoea, abdominal pain, metallic taste or loss of appetite.​

Serious but uncommon risks include lactic acidosis (from metformin), severe hypoglycaemia, or allergic reactions, which require urgent medical care.​

Precautions & Contraindications

• Contraindicated in type 1 diabetes, diabetic ketoacidosis, severe renal impairment, severe liver disease, acute alcohol intoxication, and states predisposing to lactic acidosis (e.g., severe infection, shock).​

• Caution is required in elderly, malnourished patients, those with irregular meals, or performing heavy exercise, due to hypoglycaemia risk.​

• Temporary discontinuation may be required before major surgery or contrast imaging; alcohol intake should be limited.​

Use in pregnancy and breastfeeding should be guided by specialists; insulin is often preferred.​

10 Frequently Asked Questions (FAQ)

1. What is FORMIGRAM‑GZ Tablet used for?
It is used to treat type 2 diabetes in adults when diet, exercise and metformin alone do not adequately control blood sugar.​

2. How does it work?
Gliclazide stimulates insulin secretion from pancreatic beta‑cells, while metformin reduces hepatic glucose output and improves peripheral insulin sensitivity.​

3. When should I take it?
Usually once or twice daily with meals (breakfast and/or dinner), as advised by the doctor, to reduce hypoglycaemia and stomach upset.​

4. Can FORMIGRAM‑GZ cause low blood sugar?
Yes; skipping meals, heavy exercise or alcohol can precipitate hypoglycaemia, so patients should recognise symptoms and carry fast‑acting sugar.​

5. What if I miss a dose?
Take it with the next meal if remembered soon; if it is close to the next dose, skip the missed dose—do not double up.​

6. Is it safe for kidney patients?
Suitability and dose depend on kidney function; moderate‑to‑severe renal impairment may require dose changes or avoidance of metformin.​

7. Can I take it with other diabetes medicines?
Doctors may combine it with other oral agents or insulin, but this increases hypoglycaemia risk and must be supervised.​

8. Does it cause weight gain?
Sulfonylureas like gliclazide can be associated with modest weight gain, especially if diet is not controlled.​

9. How long do I need to take it?
Type 2 diabetes is chronic, so treatment is usually long term; do not stop without your doctor’s advice.​

10. What warning signs need urgent attention?
Severe or persistent vomiting, abdominal pain, deep or rapid breathing, extreme weakness (possible lactic acidosis) or severe hypoglycaemia symptoms require immediate medical care.​

Quick Tips

• Always take FORMIGRAM‑GZ Tablet with food at a fixed time daily.​

• Keep glucose tablets, sugar or juice handy for sudden low sugar, and avoid skipping meals.​

• Monitor blood sugar and HbA1c regularly and attend routine checks for kidney and liver function.​

Why Choose Ingram BioSciences?

FORMIGRAM‑GZ Tablet is part of Ingram BioSciences’ dedicated Cardio‑Diabetes Care portfolio, alongside products like DAPING 10 and LYPGEN 100 for comprehensive metabolic care. Ingram operates from its Jasola, New Delhi base with a strong distribution and PCD/franchise network and emphasizes clear product information and prescriber‑only use.​

This makes FORMIGRAM‑GZ a credible gliclazide‑metformin SR option for Indian clinicians, hospitals and franchise partners.​

Customer Support & Ordering

For queries about FORMIGRAM‑GZ Tablet or other Ingram products:

• Company: Ingram Biosciences Pvt Ltd.​

• Delhi Office: Office‑308, 3rd Floor, Living Style Mall, Jasola, New Delhi – 110025, India.​

• Phone / WhatsApp: +91 99997 81444; Mobile: +91 76690 11534.​

• Email: info@ingrambiosciences.in​

The product is available through hospitals, retail chemists, PCD/franchise channels and major e‑pharmacies, and must only be used on prescription of a registered medical practitioner.​